Retrieved from https://studentshare.org/nursing/1651225-multipe-sclerosis
https://studentshare.org/nursing/1651225-multipe-sclerosis.
Multiple Sclerosis The disorder, also known as MS impairs the central nervous system making transmission of information from the brain to the rest of the body hard. The disease is not immune select, and the cause of it is not yet known. Additionally, MS affects people from the age of 20 to 40 and its cure has not yet been discovered. However, patients can still extend their lifespan by taking the diet recommended to them (Alkhawajah et al. 2013).Pathophysiology of multiple sclerosisWeiner and Stankiewicz (2012) wrote that the disease affects the body, mainly by impairing the nervous system since it affects the myelin which covers the nerve cells resulting to brain disorders.
In addition, the damage of the myelin sheath makes it difficult for the brain to transmit signals to parts of the body. Also, due to the effect on the brain, patients lack balance, that results to physical inactiveness and the patient remains dull. The disease also weakens the limbs, causing difficult movement.SymptomsMS patients experience blurred vision or in some instance double vision. This may be caused by the brain not transmitting information to the eye. Patients also suffer scantiness of coordination leading to clumsiness and feebleness in the limbs.
Moreover, a common symptom is lack of balance leading to problems in walking whereby a patient may fall. Additionally, close to 90% of the patient experience fatigue causing weak muscles (Weiner & Stankiewicz 2012).Tests used to diagnoseThe tests for the disorder are mainly Magnetic Resonance Imaging and Computed tomography. These two tests involve studying the cells. The cells later draw up patterns that help the observer to determine whether there is the presence of the infection in the cells.
The observation made by the clinic officer later helps them determine which kind of treatment to use, either clinical or surgical (Constantino et al. 2012).TreatmentConstantino et al. (2012) explain that the treatment could be by use of biomarkers being introduced to the body of the patient. Interferon-beta can also be used by neutralizing antibodies in the patient’s body. However, the clinician should take time to evaluate the patient’s body response to different biomarkers so as to ensure that the patient is treated with the biomarker that reacts positively with the body.
ReferencesAlkhawajah, M., Caminero, A., Freeman, H., & Oger, J. (2013). Multiple Sclerosis and Inflammatory Bowel Diseases: What We Know And What We Would Need To Know!. Multiple Sclerosis Journal, 19(3), 259-265.Constantino, C., Rodrigues, R., Neto, J., Marchiori, E., Araujo, A., de Mello Perez, R., & Parente, D. (2014). Computed Tomography and Magnetic Resonance Enterography Findings in Crohns Disease: What Does The Clinician Need To Know From The Radiologist. Canadian Association of Radiologists Journal, 65(1), 42-51.Weiner, H., L.
& Stankiewicz, J., M. (2012). Multiple Sclerosis: Diagnosis and Therapy. West Sussex, UK: John Wiley & Sons.
Read More